These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33306471)

  • 1. High-Throughput Screening and Quantum Mechanics for Identifying Potent Inhibitors Against Mac1 Domain of SARS-CoV-2 Nsp3.
    Selvaraj C; Dinesh DC; Panwar U; Boura E; Singh SK
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1262-1270. PubMed ID: 33306471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.
    Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33158944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.
    Roy A; Alhammad YM; McDonald P; Johnson DK; Zhuo J; Wazir S; Ferraris D; Lehtiö L; Leung AKL; Fehr AR
    Antiviral Res; 2022 Jul; 203():105344. PubMed ID: 35598780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3.
    Virdi RS; Bavisotto RV; Hopper NC; Vuksanovic N; Melkonian TR; Silvaggi NR; Frick DN
    SLAS Discov; 2020 Dec; 25(10):1162-1170. PubMed ID: 32981460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.
    Brosey CA; Houl JH; Katsonis P; Balapiti-Modarage LPF; Bommagani S; Arvai A; Moiani D; Bacolla A; Link T; Warden LS; Lichtarge O; Jones DE; Ahmed Z; Tainer JA
    Prog Biophys Mol Biol; 2021 Aug; 163():171-186. PubMed ID: 33636189
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Xie S; Cao S; Wu J; Xie Z; Liu YT; Fu W; Zhao Q; Liu L; Yang L; Li J
    J Biomol Struct Dyn; 2024 Jul; 42(10):5229-5237. PubMed ID: 37349935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Basis for ADP-Ribose Binding to the Mac1 Domain of SARS-CoV-2 nsp3.
    Frick DN; Virdi RS; Vuksanovic N; Dahal N; Silvaggi NR
    Biochemistry; 2020 Jul; 59(28):2608-2615. PubMed ID: 32578982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain.
    Sherrill LM; Joya EE; Walker A; Roy A; Alhammad YM; Atobatele M; Wazir S; Abbas G; Keane P; Zhuo J; Leung AKL; Johnson DK; Lehtiö L; Fehr AR; Ferraris D
    Bioorg Med Chem; 2022 Aug; 67():116788. PubMed ID: 35597097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
    Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
    bioRxiv; 2020 Oct; ():. PubMed ID: 32511412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study.
    Singh AK; Kushwaha PP; Prajapati KS; Shuaib M; Gupta S; Kumar S
    Comput Biol Med; 2021 Mar; 130():104185. PubMed ID: 33352458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors.
    Yazdani B; Sirous H; Brogi S; Calderone V
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo.
    Taha TY; Suryawanshi RK; Chen IP; Correy GJ; McCavitt-Malvido M; O'Leary PC; Jogalekar MP; Diolaiti ME; Kimmerly GR; Tsou CL; Gascon R; Montano M; Martinez-Sobrido L; Krogan NJ; Ashworth A; Fraser JS; Ott M
    PLoS Pathog; 2023 Aug; 19(8):e1011614. PubMed ID: 37651466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment.
    Jung LS; Gund TM; Narayan M
    Protein J; 2020 Dec; 39(6):619-630. PubMed ID: 33185784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
    Zhao Y; Du X; Duan Y; Pan X; Sun Y; You T; Han L; Jin Z; Shang W; Yu J; Guo H; Liu Q; Wu Y; Peng C; Wang J; Zhu C; Yang X; Yang K; Lei Y; Guddat LW; Xu W; Xiao G; Sun L; Zhang L; Rao Z; Yang H
    Protein Cell; 2021 Nov; 12(11):877-888. PubMed ID: 33864621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.
    Roy A; Alhammad YM; McDonald P; Johnson DK; Zhuo J; Wazir S; Ferraris D; Lehtiö L; Leung AKL; Fehr AR
    bioRxiv; 2022 Mar; ():. PubMed ID: 35262075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain.
    Dasovich M; Zhuo J; Goodman JA; Thomas A; McPherson RL; Jayabalan AK; Busa VF; Cheng SJ; Murphy BA; Redinger KR; Alhammad YMO; Fehr AR; Tsukamoto T; Slusher BS; Bosch J; Wei H; Leung AKL
    ACS Chem Biol; 2022 Jan; 17(1):17-23. PubMed ID: 34904435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations.
    Arwansyah A; Arif AR; Ramli I; Kurniawan I; Sukarti S; Nur Alam M; Illing I; Farid Lewa A; Manguntungi B
    SAR QSAR Environ Res; 2021 Sep; 32(9):699-718. PubMed ID: 34392751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.
    Chea C; Lee DY; Kato J; Ishiwata-Endo H; Moss J
    bioRxiv; 2023 Feb; ():. PubMed ID: 36945431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GS-441524-Diphosphate-Ribose Derivatives as Nanomolar Binders and Fluorescence Polarization Tracers for SARS-CoV-2 and Other Viral Macrodomains.
    Peng K; Wallace SD; Bagde SR; Shang J; Anmangandla A; Jana S; Fromme JC; Lin H
    ACS Chem Biol; 2024 May; 19(5):1093-1105. PubMed ID: 38646883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors.
    O'Connor JJ; Ferraris D; Fehr AR
    Pathogens; 2023 Oct; 12(10):. PubMed ID: 37887737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.